Johnson Chemical Pharmaceutical Works (4747.TWO) Earnings Analysis
Johnson Chemical Pharmaceutical Works (4747.TWO) has no confirmed upcoming earnings date. Trailing P/E 22.72.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4747.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 4747.TWO. This page updates as the calendar is published.
4747.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | 0.43 TWD | n/a | n/a | n/a |
| 2025-03-31 | 0.47 TWD | n/a | n/a | n/a |
| 2024-12-31 | 0.4276 TWD | n/a | n/a | n/a |
| 2024-09-30 | 0.47 TWD | n/a | n/a | n/a |
4747.TWO valuation and analyst view
| Trailing P/E | 22.72 |
|---|---|
| Trailing EPS | 2.163 TWD |
| Price / book | 1.27 |
| Dividend yield | 2.13% |
| Market cap | 2.22B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Johnson Chemical Pharmaceutical Works (4747.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 4747.TWO. This page updates as the calendar is published.
Did 4747.TWO beat earnings last quarter?
Consensus estimate data was not available for 4747.TWO's 2025-06-30 report.
What is 4747.TWO's current P/E ratio and EPS?
4747.TWO trades at a trailing P/E of 22.72 on trailing EPS of 2.1627548549033424 TWD.
What do analysts rate 4747.TWO?
4747.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.